Pierandrea Muglia
Directeur/Membre du Conseil chez SANA AB
Profil
Pierandrea Muglia is an Independent Director at Saniona AB since 2023.
Previously, he worked as the Vice President & Head-Experimental Medicine at NTG Nordic Transport Group A and as the Chief Marketing Officer at Handl Therapeutics BV.
Postes actifs de Pierandrea Muglia
| Sociétés | Poste | Début |
|---|---|---|
| SANA AB | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Pierandrea Muglia
| Sociétés | Poste | Fin |
|---|---|---|
| GRIN Therapeutics, Inc. | Fondateur | 01/09/2022 |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 01/10/2019 |
Handl Therapeutics BV
 Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Sales & Marketing | - |
| NTG NORDIC TRANSPORT GROUP A/S | Directeur/Membre du Conseil | 28/05/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| SANA AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
UCB Pharma SA (Belgium)
UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Health Technology |
Handl Therapeutics BV
Handl Therapeutics BV BiotechnologyHealth Technology Handl Therapeutics BV engages in the provision of gene therapy treatment solutions. It develops medicine for the treatment of complex neurodegenerative diseases. The company was founded by Florent Gros and Michael R. Linden in 2019 and is headquartered in Louvain, Belgium. | Health Technology |
| GRIN Therapeutics, Inc. |
